Sei Investments CO Amylyx Pharmaceuticals, Inc. Transaction History

Sei Investments CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$27.71 - $40.93 $1.55 Million - $2.29 Million	55,888 Added 405.66%	69,665 $2.04 Million
Q4 2022 Feb 10, 2023	SELL	$29.75 - $39.26 $1.48 Million - $1.96 Million	-49,897 Reduced 78.36%	13,777 $509,000
Q3 2022 Nov 14, 2022	SELL	$17.15 - $30.92 $517,586 - $933,165	-30,180 Reduced 32.16%	63,674 $1.79 Million
Q2 2022 Aug 15, 2022	BUY	$6.85 - $19.93 $642,899 - $1.87 Million	93,854 New	93,854 $1.81 Million

139

46.5M

226K

909K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $290M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.